Stamford, CT -- (SBWIRE) -- 12/06/2013 -- Jet Life Penny Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: ALACER GOLD CORP (OTCMKTS:ALIAF), B Provectus Pharmaceuticals, Inc.(OTCMKTS:PVCT), AMARANTUS BIOSCIENCE HOLDINGS, INC.(OTCBB:AMBS), Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY)
ALACER GOLD CORP (OTCMKTS:ALIAF) increased 0.39% at the price of $1.95 recently on a traded volume of 70,500.00 shares, in comparison to 23,864.00 shares of average trading volume. So far this year, the stock is down over -62.55%.
The company has a total market capitalization of $557.46 million. Alacer Gold Corp., an intermediate gold mining company, engages in the exploration and production of gold in Australia and Turkey. The company holds an 80% interest in the Çöpler gold mine located to the southwest of Erzincan, Turkey. Its exploration projects include Cevizlidere, Çöpler Sulfides, and Karakartal projects located in Turkey. The company was formerly known as Anatolia Minerals Development Limited and changed its name to Alacer Gold Corp. in February 2011. Alacer Gold Corp. is based in Englewood, Colorado.
For How Long ALIAF will Fight for Profitability? Read This Trend Analysis report
B Provectus Pharmaceuticals, Inc.(OTCMKTS:PVCT) soared 6.12% at the trading price of $0.99 on a traded volume of 434,115.00 shares till now, whereas its average trading volume is 474,001.00 shares. In the last three months, the stock is up 57.58%. The Intra-day range for the stock is $0.99 and $1.04. Provectus Pharmaceuticals, Inc. is a development-stage pharmaceutical company that is primarily engaged in developing ethical pharmaceuticals for oncology and dermatology indications. T
For How Long PVCT Gloss will Attract Investors? Find out via this report
AMARANTUS BIOSCIENCE HOLDINGS, INC.(OTCBB:AMBS) dropped down -5.50% at the $0.055 recently. The 52-week range for the stock is $0.027 and $0.20. Its introductory price for the day was $0.0589, with the overall traded volume of 1.91million shares. Amarantus BioScience Holdings, Inc., a development-stage biotechnology company, focuses on the discovery and development of drug candidates and diagnostic blood tests to diagnose and treat human diseases in the United States
Why Should Investors Buy AMBS After the Recent Fall? Just Go Here and Find Out
Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) after opening its shares at the price of $68.72, jumped up 0.42% , its recent trading price was $68.71 for the day. The stock moved on a traded volume of 51,536.00 shares, in comparison to 354,494.00 shares of average trading volume.
The 52-week range for the stock is $48.97 and $70.52. Its introductory price for the day was $68.72. Roche Holding AG is a Swiss pharmaceuticals and diagnostics holding company. It belongs to the Roche Group that operates through subsidiaries and associated companies around the world.
Why Should Investors Buy RHHBY After The Recent Gain? Just Go Here and Find Out
Jet Life Penny Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to. Our Penny Stock Newsletter also offers free Highly-Professional Grade stock charts and video charts from one of the most experienced and well-respected chartists in the penny stock industry.
Jet Life Penny Stocks is not a registered securities advisor. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides information on highlighted stocks via press releases, newsletters and company website, but this should not be construed as a recommendation to buy or sell. Please visit the company website for a more complete list of risks and disclosures.
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)